Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program
dc.contributor.author | Ersoz, G. | |
dc.contributor.author | Erol, C. | |
dc.contributor.author | Kaymakoglu, S. | |
dc.contributor.author | Iliaz, R. | |
dc.contributor.author | Ozgenel, M. | |
dc.contributor.author | Toka, B. | |
dc.contributor.author | Karasu, Z. | |
dc.contributor.author | Kiyici, M. | |
dc.contributor.author | Akdogan, M. | |
dc.contributor.author | Turkey, E. A. P. | |
dc.contributor.author | Cavus, B. | |
dc.contributor.author | Idilman, R. | |
dc.contributor.author | Demir, M. | |
dc.contributor.author | Aladag, M. | |
dc.contributor.author | Akarca, U. S. | |
dc.contributor.author | Koklu, S. | |
dc.contributor.author | Cakaloglu, Y. | |
dc.contributor.author | Sahin, M. | |
dc.contributor.author | Koksal, I. | |
dc.date.accessioned | 2021-03-05T17:07:58Z | |
dc.date.available | 2021-03-05T17:07:58Z | |
dc.identifier.citation | Idilman R., Demir M., Aladag M., Kaymakoglu S., Erol C., Cavus B., Iliaz R., Akarca U. S. , Koklu S., Cakaloglu Y., et al., "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program", International Liver Congress (ILC), Paris, Fransa, 11 - 15 Nisan 2018, cilt.68 | |
dc.identifier.other | av_c4160660-5cc7-492b-8356-e19e4a8a6391 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/130058 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.title | Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program | |
dc.type | Bildiri | |
dc.contributor.department | Ankara Üniversitesi , , | |
dc.identifier.volume | 68 | |
dc.contributor.firstauthorID | 153277 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]